Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings

Thrombosis Research

Volumn 84, Issue 3, 1996, Pages 167-177

  Yang, Li Hui ^a   Hoppensteadt, Debra A ^a   Iqbal, Omer ^a   Fareed, Jawed ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

arterial smooth muscle ring; defibrotide; endothelin I; serotonin; serum and thromboxane

Indexed keywords

ARACHIDONIC ACID; DEFIBROTIDE; ENDOTHELIN 1; HEPARIN; SEROTONIN; THROMBOXANE A2;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; DOG; FEMORAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; VASCULAR SMOOTH MUSCLE;

EID: 0030297588     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00173-9     Document Type: Article

References (16)

1. FAREED, J., KINDEL, G. and WALENGA, J.M. Pharmacological validation of the antithrombotic and vascular effects of defibrotide. In: Advances in Vascular Pathology, Strano A, Novo S (eds.), Elsevier Science Publishers B.V. (Biomedical Division), Amsterdam-New York-Oxford, 1990, pp 171-215.
2. FAREED J., WALENGA J.M., HOPPENSTEADT D.A., KUMAR A., ULUTIN O.N., CORNELLI U. Pharmacologic profiling of defibrotide in experimental models. Semin Thromb Hemost. 14:1988;27-37.
3. KINDEL, G., FAREED, J. and WALENGA, J.M. Modulation of endothelin induced contraction of rabbit and rat aortic strips by a polydeoxyribonucleotide (defibrotide). Thromb Haemost 65: 1251(A 2009), 1991.
4. CORNELLI U, NAZZARI M Defibrotide: an overview of clinical pharmacology and early clinical studies. Semin Thromb Hemost. 14((Suppl 1)):1988;64-70.
5. ULUTIN ON., ILHAN-BERKEL N., TUNALI H., OEZER M., BALKUV-ULUTIN S., OENSEL C., URGANCIOGLU I. Effects of defibrotide on peripheral obliterative vascular diseases. Haemostasis. 16((suppl 1)):1986;59-62.
6. CIMMINIELLO C. Clinical trials with defibrotide in vascular disorders. Semin Thromb Hemost. 22((suppl 1)):1996;29-34.
7. STRANO A., FAREED J., SABBA C., ALBANO O., ALLEGRA C., CARLIZZA A., BINAGHI F., FRONTEDDU F., GUERCIO R.DEL., ARPAIA M.R., PINTO A., ALLETO G., WALENGEN J.M., HOPPENSTEADT D., NAZZARRI M., FERRARI P.A. A double blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: Preliminary results in patients with peripheral arterial disease. Semin Thromb Hemost. 17((suppl 2)):1991;228-234.
8. CAGNAZZO D. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological clinical trial. Haemostasis. 16((suppl 1)):1986;39-41.
9. FAREED J., KINDEL G., KUMAR A. Modulation of smooth muscle responses by serine proteases and related enzymes. Semin Thromb Hemost. 12:1986;265-276.
10. COCCHERI S., BIAGI G. Defibrotide. Cardiovasc Drugs Rev. 9:1991;172-196.
11. COCCHERI S., Nazzari M. Defibrotide as a possible anti-ischemic drug. Semin Thromb Hemost. 22((suppl 1)):1996;9-14.
12. BERTI F., ROSSONI G., NIADA R., FOLCO G., OMINI C., TONDO C. Defibrotide, an antithrombotic substance that preserves postsynaptic α- and β-adrengergic function in post acute infarcted rabbit hearts. J. Cardiovasc Pharmacol. 8:1986;235-240.
13. BERTI F., ROSSONI G., BIASI G., BUSCHI A., MANDELLI V., TONDO C. Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous vein. Prostaglandins. 40:1990;337-350.
14. LEFER A.M., AOKI N., MULLYOY D. Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion. Naunyn-Schmiedeberg's Arch Pharmacol. 341:1990;246-250.
15. SABBA C., ZUPO V., DINA F., Nazzari M., ALBANO O. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease. Int J. Clin Pharmacol Ther Toxicol. 26:1988;249-252.
16. MA X.L., PORTA R., PESCADOR R., LEFER A.M. Novel beneficial mechanism of defibrotide, a prostcyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats. Meth Find Exp Clin Pharmacol. 13:1991;667-674.